These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 22531127)
1. Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. Hughes LA; Williamson EJ; van Engeland M; Jenkins MA; Giles GG; Hopper JL; Southey MC; Young JP; Buchanan DD; Walsh MD; van den Brandt PA; Alexandra Goldbohm R; Weijenberg MP; English DR Int J Epidemiol; 2012 Aug; 41(4):1060-72. PubMed ID: 22531127 [TBL] [Abstract][Full Text] [Related]
2. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study. Wish TA; Hyde AJ; Parfrey PS; Green JS; Younghusband HB; Simms MI; Fontaine DG; Dicks EL; Stuckless SN; Gallinger S; McLaughlin JR; Woods MO; Green RC Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1831-9. PubMed ID: 20570909 [TBL] [Abstract][Full Text] [Related]
3. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154 [TBL] [Abstract][Full Text] [Related]
4. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer. Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534 [TBL] [Abstract][Full Text] [Related]
5. Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. English DR; Young JP; Simpson JA; Jenkins MA; Southey MC; Walsh MD; Buchanan DD; Barker MA; Haydon AM; Royce SG; Roberts A; Parry S; Hopper JL; Jass JJ; Giles GG Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1774-80. PubMed ID: 18628431 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer. Nakaji Y; Oki E; Nakanishi R; Ando K; Sugiyama M; Nakashima Y; Yamashita N; Saeki H; Oda Y; Maehara Y J Cancer Res Clin Oncol; 2017 Jan; 143(1):151-160. PubMed ID: 27672042 [TBL] [Abstract][Full Text] [Related]
7. Marine ω-3 polyunsaturated fatty acids and risk of colorectal cancer according to microsatellite instability. Song M; Nishihara R; Wu K; Qian ZR; Kim SA; Sukawa Y; Mima K; Inamura K; Masuda A; Yang J; Fuchs CS; Giovannucci EL; Ogino S; Chan AT J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25810492 [TBL] [Abstract][Full Text] [Related]
8. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. Limsui D; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Harnack LJ; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ J Natl Cancer Inst; 2010 Jul; 102(14):1012-22. PubMed ID: 20587792 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers. de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292 [TBL] [Abstract][Full Text] [Related]
10. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer. Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726 [TBL] [Abstract][Full Text] [Related]
11. Somatic BRAF-V600E mutations in familial colorectal cancer. Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056 [TBL] [Abstract][Full Text] [Related]
12. Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation. Tie J; Gibbs P; Lipton L; Christie M; Jorissen RN; Burgess AW; Croxford M; Jones I; Langland R; Kosmider S; McKay D; Bollag G; Nolop K; Sieber OM; Desai J Int J Cancer; 2011 May; 128(9):2075-84. PubMed ID: 20635392 [TBL] [Abstract][Full Text] [Related]
13. Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study. Brändstedt J; Wangefjord S; Nodin B; Eberhard J; Sundström M; Manjer J; Jirström K PLoS One; 2014; 9(2):e98964. PubMed ID: 24918610 [TBL] [Abstract][Full Text] [Related]
14. MSI status is associated with distinct clinicopathological features in BRAF mutation colorectal cancer: A systematic review and meta-analysis. Wu M; Kim YS; Ryu HS; Choi SC; Kim KY; Park WC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY Pathol Res Pract; 2020 Jan; 216(1):152791. PubMed ID: 31866097 [TBL] [Abstract][Full Text] [Related]
15. BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics. Phipps AI; Buchanan DD; Makar KW; Burnett-Hartman AN; Coghill AE; Passarelli MN; Baron JA; Ahnen DJ; Win AK; Potter JD; Newcomb PA Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1792-8. PubMed ID: 22899730 [TBL] [Abstract][Full Text] [Related]
16. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations. Preto A; Figueiredo J; Velho S; Ribeiro AS; Soares P; Oliveira C; Seruca R J Pathol; 2008 Feb; 214(3):320-7. PubMed ID: 18098337 [TBL] [Abstract][Full Text] [Related]
17. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS Hum Pathol; 2007 Jun; 38(6):842-9. PubMed ID: 17350669 [TBL] [Abstract][Full Text] [Related]
18. Risk Factors and Incidence of Colorectal Cancer According to Major Molecular Subtypes. Wang L; He X; Ugai T; Haruki K; Lo CH; Hang D; Akimoto N; Fujiyoshi K; Wang M; Fuchs CS; Meyerhardt JA; Zhang X; Wu K; Chan AT; Giovannucci EL; Ogino S; Song M JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442661 [TBL] [Abstract][Full Text] [Related]
19. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status. Dahlin AM; Palmqvist R; Henriksson ML; Jacobsson M; Eklöf V; Rutegård J; Oberg A; Van Guelpen BR Clin Cancer Res; 2010 Mar; 16(6):1845-55. PubMed ID: 20197478 [TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women. Limsui D; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Harnack LJ; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ Gut; 2012 Sep; 61(9):1299-305. PubMed ID: 22027477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]